BRCA1 and cancer: Finally, despite the increase in throughput and the extended scope for BRCA1/2 variant discovery, less than 10% of patients with a personal history of cancer diagnosed at an early age, or who had a positive family history, received a positive test result, leaving the remainder of patients still in the dark regarding alternative management and therapeutic options involving poly (ADP-ribose) (PARP) inhibitors.